Guillian Barre; partial paralysis; Extreme fatique; slurred speech; incomplete thoughts; I spent days in bed; Lost months of work time / Could not work, drive, walk, talk; Could not walk; could not talk; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 07May2021 (Lot number: EW0170) at the age of 45 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies:Penicillin" (unspecified if ongoing), notes: Known allergies:Penicillin. The patient took concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Batch/Lot No: EW0158, Location of injection: Arm Left), administration date: 10Apr2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: GUILLAIN-BARRE SYNDROME (disability, medically significant) with onset 01Jun2021, outcome "not recovered", described as "Guillian Barre"; PARALYSIS (disability, medically significant) with onset 01Jun2021, outcome "not recovered", described as "partial paralysis"; FATIGUE (disability) with onset 01Jun2021, outcome "not recovered", described as "Extreme fatique"; DYSARTHRIA (disability) with onset 01Jun2021, outcome "not recovered", described as "slurred speech"; THINKING ABNORMAL (disability) with onset 01Jun2021, outcome "not recovered", described as "incomplete thoughts"; BEDRIDDEN (disability) with onset 01Jun2021, outcome "not recovered", described as "I spent days in bed"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (disability) with onset 01Jun2021, outcome "not recovered", described as "Lost months of work time / Could not work, drive, walk, talk"; GAIT INABILITY (disability) with onset 01Jun2021, outcome "not recovered", described as "Could not walk"; SPEECH DISORDER (disability) with onset 01Jun2021, outcome "not recovered", described as "could not talk". The events "guillian barre", "partial paralysis", "extreme fatique", "slurred speech", "incomplete thoughts", "i spent days in bed", "lost months of work time / could not work, drive, walk, talk", "could not walk" and "could not talk" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative; negative. Therapeutic measures were taken as a result of guillain-barre syndrome. Therapeutic measures were not taken as a result of paralysis, fatigue, dysarthria, thinking abnormal, bedridden, loss of personal independence in daily activities, gait inability, speech disorder. Clinical course: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. Reported Events: Extreme fatigue, partial paralysis, slurred speech, incomplete thoughts. The patient spent days in bed. Lost months of work time. Could not work, drive, walk, talk. The patient went to my primary Doctor, Neurologist, and ER. They all said, "I do not know what is wrong with you." The patient hormone replacement clinician told that the patient have Guillion Barre. The patient went to a functional medicine physician, and he agreed. The physician was currently treating the patient for Guillian Barre. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19.